Thursday, March 25, 2021

121-day torch relay through Japan begins ahead of delayed Tokyo Olympics

torch-relay-032421

The torch relay for the postponed Tokyo Olympics began its 121-day journey across Japan on Thursday and is headed toward the opening ceremony in Tokyo on July 23.



source https://www.cbc.ca/sports/olympics/olympic-torch-relay-begins-1.5963014?cmp=rss

Biden faces early North Korean test after ballistic missiles fired into Sea of Japan

1309017748

North Korea on Thursday test-fired its first ballistic missiles since U.S. President Joe Biden took office, as it expands its military capabilities and increases pressure on Washington while nuclear negotiations remain stalled.



source https://www.cbc.ca/news/world/north-korea-missiles-us-japan-1.5963265?cmp=rss

Stuck ship in Egypt's Suez Canal threatens shipping worldwide

EGYPT-SUEZCANAL/SHIP

A skyscraper-sized cargo ship wedged across Egypt's Suez Canal further imperilled global shipping Thursday as at least 150 other vessels needing to pass through the crucial waterway idled waiting for the obstruction to clear, authorities said.



source https://www.cbc.ca/news/business/suez-canal-egypt-ever-given-1.5963207?cmp=rss

The pivotal debate in U.S. politics: A rule change that would change everything for Biden

USA-BIDEN/INAUGURATION

It's the hottest debate in U.S. politics — one potential rule change that could change everything when it comes to passing laws in Congress. The Senate's filibuster rule has created a graveyard of bills over the years. Democrats could now be on the cusp of reforming it to save Joe Biden's agenda.



source https://www.cbc.ca/news/world/united-states-congress-filibuster-debate-1.5962882?cmp=rss

AstraZeneca says COVID-19 vaccine shows 76% efficacy in updated analysis of U.S. trial

1231789942

AstraZeneca said its COVID-19 vaccine had a 76 per cent efficacy rate at preventing symptomatic illness in a new analysis of its major U.S. trial — slightly lower than the level announced earlier this week in a report that was criticized for using outdated information.



source https://www.cbc.ca/news/world/astrazeneca-trial-efficacy-1.5963123?cmp=rss